Manta Launching at Bach Mai Hospital

We are proud to announce the launch of Manta Vascular Closure Device in Vietnam.

The MANTA Device is the first commercially available biomechanical vascular closure device designed specifically for large bore femoral arterial access site closure. Available in 14 Fr. and 18 Fr., a single MANTA Device effectively closes femoral arterial access sites following the use of sheaths ranging from 12 Fr. to 25 Fr. O.D.

Simple Deployment
Addresses the challenges of large bore closure with a single easy-to-use device.

Rapid Hemostasis
Reduces time to hemostasis without pre-closure, utilizing the coagulation-inducing properties of collagen for rapid hemostasis to promote vessel healing.

Reliable Closure
Delivers reproducible results and helps inspire confidence in achieving successful closure.

Clinically Proven

The SAFE MANTA IDE Clinical Trial, the largest U.S. prospective, multi-center study of a purpose-designed large bore femoral arterial access site closure device to date, demonstrated the safety and effectiveness of the MANTA Device with all primary and secondary endpoints met.

97.7% technical success rate

24 seconds median time from deployment to hemostasis (65 seconds mean time)

5.3% major complication rate and 4.2% VARC-2 Major Vascular Complication Rate (VAR-2 rate lower than published rates for suture-mediated closure)